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Hepatitis delta virus (HDV) encodes two isoforms of delta antigens (HDAgs). The small form of HDAg (SHDAg) is required for HDV RNA
replication, while the large form of HDAg (LHDAg) is required for viral assembly. Using tandem affinity purification method combined with mass
spectrometry, we found that linker histone H1e bound to SHDAg. The binding domain of SHDAg to histone H1e was mapped to the N-terminal
67 amino acids. Oligomerization of SHDAg was required for its interaction with histone H1e. LHDAg barely bound to histone H1e and was
masked at N-terminus. The binding domain of histone H1e to SHDAg was mapped to its central globular domain. HDV replication was inhibited
by N- or C-terminal deletion mutants of histone H1e and was rescued by wild-type histone H1e. We conclude that histone H1e plays a significant
role in HDV replication through forming protein complex with SHDAg.
© 2008 Elsevier Inc. All rights reserved.Keywords: Hepatitis delta antigen; Tandem affinity purification; Histone H1eIntroduction
Hepatitis delta virus (HDV) is a satellite virus of hepatitis B
virus and can cause fulminant hepatitis and accelerated liver
cirrhosis in patients with chronic hepatitis B (Smedile et al.,
1982). HDV contains a single-stranded circular RNA genome of
1.7 kb (Kos et al., 1986; Makino et al., 1987; Wang et al., 1986),
whose RNA structure resembles those of viroids, virusoids, and
plant satellite virus RNAs. HDV encodes a single protein,
hepatitis delta antigen (HDAg). HDAg consists of two distinct
species, the small hepatitis delta antigen (SHDAg) (195 amino
acids, 24 kDa) and the large hepatitis delta antigen (LHDAg)
(214 amino acids, 27 kDa) (Bonino et al., 1986; Weiner et al.,
1988). These two proteins are identical in sequence, but LHDAg
contains 19 additional amino acids at the carboxyl terminus
(Weiner et al., 1988). SHDAg is absolutely required for HDV
RNA replication (Kuo et al., 1989), while LHDAg is required for
HDV assembly (Chang et al., 1991; Ryu et al., 1992). HDV⁎ Corresponding author. No. 7 Chung Shan South Road, Taipei 100, Taiwan.
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Syntheses of HDV genomic and antigenomic RNA strands have
different sensitivities to α-amanitin and are probably mediated
by different RNA polymerases (Lai, 2005; Macnaughton et al.,
2002; Modahl et al., 2000). It has been interpreted that the
replication of antigenomic RNA to form genomic RNA may be
accomplished by DNA-dependent RNA polymerase II (Pol II),
whereas the replication of genomic RNA to form antigenomic
RNA may be mediated by a polymerase I-like enzyme. Brazas
and Ganem (1996) have identified a cellular homolog of HDAg,
termed delta-interacting protein A (DIPA), and showed that over
expression of DIPA specifically attenuated HDV RNA replica-
tion. HDAg has also been shown to bind to Pol II (Yamaguchi
et al., 2001), nucleolin (Lee et al., 1998) and nucleolar protein
B23 (Huang et al., 2001). A more recent study has demonstrated
that HDAg precipitates together with promyelocytic leukemia
protein, Pol II and the Pol I-associated transcription factor SL1,
suggesting the association of HDAg with the Pol I and Pol II
transcription machineries (Li et al., 2006).
The tandem affinity purification (TAP) method is a protein
tag-based affinity purification technique that allows rapid
purification of protein complexes under native conditions
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spectrometry, this method is very useful to identify proteins
interacting with a given target protein. Using this method, we
found that histone H1e bound to SHDAg. The interaction region
was mapped to the N-terminal domain of SHDAg. We also
found that LHDAg was masked at N-terminus and had very low
affinity to histone H1e. This masking was not related to
isoprenylation of LHDAg, but was affected by the amino acids
preceding the isoprenylation motif. Furthermore, HDV replica-
tion was inhibited by deletion mutants of histone H1e and was
rescued by wild-type histone H1e. Histone H1e likely plays a
significant role in HDV replication.
Results
Characterization of the protein complex
Initially, transfecting pCMV-TAP-S into Huh7 cells yielded no
distinct band as compared to mock-transfection control. We
suspected that the TAP tag might interfere with the binding of
SHDAg to the cellular proteins. Therefore we performed further
transfection experiment with both pCMV-TAP-S and pcDNA3-S
in a DNA ratio of 1 to 2 to co-express both TAP-tagged SHDAg
and wild-type SHDAg.We also found that COS7 cells had higher
level of protein expression than Huh7 cells when transfected with
the same plasmids. Therefore all the subsequent experiments were
performed in COS7 cells. After co-transfection and tandem
affinity purification, four bands distinct from mock-transfection
control were noted. Identification with mass spectrometry
analysis revealed histone H1e (histone H1.4), 40S ribosomal
protein S2, 60S acidic ribosomal protein P0, and 60S ribosomal
protein L4 respectively. Ribosomal proteins often contaminate
purifications because of their cellular abundance (Gavin et al.,
2002) and did not constantly showup in our repeated experiments.
We therefore focused our subsequent study on histone H1e.
Cloning of histone H1e gene
Messenger RNAs were extracted and reverse-transcribed
from COS7 cells, Huh7 cells and a human liver biopsy sample.
Histone H1e cDNA was amplified using specific primers. The
resulting sequences were deposited in Genbank (accession
number EF065553, EF065554 and EF065555 respectively).
The coding nucleotide sequences and amino acid sequences of
histone H1e from COS7 cells have 95.9% (630 /657) and 98.2%
(215 /219) homology to those from the human liver sample
respectively. The coding nucleotide sequences and amino acid
sequences of histone H1e from Huh7 cells have 99.7% (655 /
657) and 99.1% (217 /219) homology to those from the human
liver sample respectively. The resulting sequences were cloned
into pCMV-TAP and pCDNA3.1 vectors.
SHDAg interacts with histone H1e through N-terminal domain
The interaction of SHDAg with histone H1e was further
confirmed by co-transfecting pCMV-TAP-H1e or pCMV-TAP-
H-ras with pcDNA3-S into COS7 cells. Two days after trans-fection, the cell extract was purified with TAP method and
detected with anti-HDAg antibody. SHDAg was co-purified
with the TAP-tagged histone H1e derived from COS7 cells,
Huh7 cells or human liver, while not with TAP-tagged H-ras
(Fig. 1B and data not shown). Adding RNase and DNase to the
initial cell lysate did not affect the result (data not shown). This
indicated that the interaction is a genuine protein–protein
interaction. The interaction domain of SHDAg with histone H1e
was mapped using the SHDAg deletion mutants, the S2–21
(deletion of amino acids 2 to 21), containing a RNA-binding
domain (Poisson et al., 1993), S22–67 (deletion of amino acids
22 to 67), containing a coiled-coil sequence (Lasinaski and
Taylor, 1993; Wang and Lemon, 1993; Xia et al., 1992), S68–
96 (deletion of amino acids 68 to 96), containing nuclear
localization signals (Chang et al., 1992; Chou et al., 1998; Xia
et al., 1992), S97–146 (deletion of amino acids 97 to 146),
containing RNA-binding domains (Lee et al., 1993; Lin et al.,
1990), S147–168 (deletion of amino acids 147 to 168) and
S169–195 (deletion of amino acids 169 to 195) (Fig. 1A). We
co-transfected pCMV-TAP-H1e with plasmids expressing these
respective SHDAg deletion mutants into COS7 cells. Two days
after transfection, the cell extract was purified with TAP method
and detected with anti-HDAg antibody. The binding affinities of
S2–21, S22–67, S68–96, S97–146, S147–168 and S169–195
were 0%, 0%, 43%, 56%, 35% and 110% of that of SHDAg
respectively by densitometry measurement (Fig. 1C). This
implied that N-terminal amino acids 2 to 67 of SHDAg are
essential for interacting with histone H1e. The amino acids 30
to 51 of SHDAg contain a leucine zipper-like sequence that is
essential for its oligomerization (Xia and Lai 1992). We
constructed two plasmids expressing site-specific mutants of
SHDAg, SLGLL and SLGGL, which replaced the middle one
or two leucine residues in the leucine zipper-like region with
glycine respectively (Fig. 1A) and were defective in oligomer-
ization (Xia and Lai, 1992). The two mutants were assayed for
their binding affinity to histone H1e by co-transfection with
pCMV-TAP-H1e and purification with TAP method. Immuno-
blot analysis of the cell lysates showed that the signal intensity
of the two SHDAg mutants was less than that of wild-type
SHDAg (Fig. 1D, lysate). Defective in oligomerization prob-
ably made these two mutants unstable or not well recognized by
our human anti-HDAg antibody. No trace amount of these
two mutants was detected after purification by TAP method
(Fig. 1D, TAP), even after prolonged exposure of blot mem-
brane. This result suggested that oligomerization of SHDAg is
required for its interaction with histone H1e.
LHDAg has low affinity to histone H1e and is masked at the
N-terminus
LHDAg has identical amino acid sequences to SHDAg with
additional C-terminal 19 amino acids and supposedly should
have the same affinity to histone H1e. To test whether LHDAg
also binds to histone H1e, we co-transfected pcDNA3-L with
pCMV-TAP-H1e into COS7 cells. Two days after transfection,
the cellular protein was purified by TAPmethod and detected by
anti-HDAg antibody. Surprisingly, LHDAg barely bound to
Fig. 2. Probing of LHDAg with N-terminus specific anti-HDAg antibody. COS7
cells were transfected with same amount of plasmids expressing SHDAg,
LHDAg or various deletion mutants of SHDAg. Cells were harvested 2 days
after transfection, and subjected to immunoblot analysis with a human anti-
HDAg antibody (top) or an N-terminus specific anti-HDAg antibody (bottom).
The structure of the SHDAg deletion mutants was shown in Fig. 1A.
Fig. 1. Mapping of histone H1e interacting domain in SHDAg. (A) Schematic
diagram of the structure of SHDAg mutants. The two numbers in the name of the
mutant SHDAg denote the beginning and the end of the deleted amino acid
sequences. The single line in the diagram represents deleted sequences. The
leucine zipper-like sequences (amino acid 30–51) are shown and mutated
sequences are underlined. SLGLL: mutation of the 2nd leucine repeats to glycine.
SLGGL: mutations of the 2nd and 3rd leucines to glycines. (B) Same amount of
plasmids expressing TAP-tagged histone H1e or TAP-tagged H-ras were co-
transfected with plasmid expressing SHDAg into COS7 cells. (C) Same amount of
plasmids expressing LHDAg, wild-type, various deletion mutants or (D) site-
specific mutants of SHDAg were co-transfected with plasmid expressing TAP-
tagged histone H1e into COS7 cells. Above cells were lysed 2 days after
transfection, and protein was purified with TAP method. The initial lysates and
final eluates (denoted as TAP) were subjected to immunoblot analysis using a
human anti-HDAg antibody.
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affinity of LHDAg to histone H1e was estimated to be less than
40 times of that of SHDAg by densitometry measurement (datanot shown). We suspected that interacting region of HDAg with
histone H1e might be masked in LHDAg, and therefore used an
N-terminus specific monoclonal antibody of HDAg to detect
LHDAg. The binding affinities of S2–21, S22–67, S68–96,
S97–146, S147–168, S169–195 and LHDAg to this antibody
were 0%, 0%, 120%, 350%, 42%, 91% and 0% of that of
SHDAg respectively by densitometry measurement. (Fig. 2).
The result showed that LHDAg could not be detected by this
antibody. LHDAg is isoprenylated on the CRPQ motif at the
C-terminus. Isoprenylation causes the masking of a region of
32 amino acids at the C-terminus of small HDAg (Hwang
and Lai 1994). To test whether isoprenylation also masks the
N-terminus of LHDAg, we used vectors expressing mutant
LHDAgs that either can be isoprenylated (PECE-I1) or cannot
be isoprenylated (PECE-I2 and PECE-I3) (Lee et al., 1994).
All the isoprenylation mutants, like wide-type LHDAg, were
masked at N-terminus (Fig. 3C, bottom). They also had low
affinity to histone H1e (Fig. 3B, TAP). This result showed
that the masking of N-terminus is not caused by isoprenylation
and suggested that the 15 amino acids preceding the isoprenyl-
ation motif might contribute to the masking of N-terminus
of LHDAg. We expressed three mutant LHDAgs that had
N-terminal (PECE-N5), middle (PECE-M5) or C-terminal
(PECE-C5) deletion of 5 amino acids from this stretch of se-
quences (Lee et al., 1994) respectively. Only mutant LHDAg
expressed by PECE-N5 could be detected by N-terminus spe-
cific monoclonal antibody (Fig. 3C, bottom) and showed sig-
nificant binding to histone H1e (Fig. 3B, TAP). We concluded
that LHDAg is masked at N-terminus, caused by amino acid
residues immediately following SHDAg sequences, and thus has
low affinity to histone H1e.
Histone H1e interacts with SHDAg through globular domain
Linker histone H1 contains three distinct domains: a short
amino-terminal domain (20–35 amino acids), a central glob-
ular domain (80 amino acids, consisting of a helix bundle and
a-hairpin), and a long carboxyl-terminal domain (100 amino
acids) (Hartman et al., 1977). To map the domain interacting
Fig. 4. Mapping of SHDAg interacting domain in histone H1e. (A) Schematic
diagram of structure of histone H1e mutants. The single line in the diagram
represents deleted sequences. (B) Same amount of plasmids expressing various
TAP-tagged histone H1e deletion mutants was co-transfected with plasmid
expressing SHDAg into COS7 cells. Cells were lysed 2 days after transfection.
Protein bound to TAP-tagged mutant histone H1e was purified with TAP
method. The initial lysates and final eluates (denoted as TAP) were subjected to
immunoblot analysis using a human anti-HDAg antibody.
Fig. 3. Interaction of isoprenylation mutants and deletion mutants of the last 19
amino acids unique to the LHDAg with histone H1e. (A) Schematic diagram of
the structure of LHDAg mutants. The hatched box denotes 15 amino acids
preceding isoprenylation motif (CRPQ). The single lines in N5, M5, and C5
represent deletion of 5 amino acids. (B) Same amount of plasmids expressing
various isoprenylation mutants or deletion mutants of LHDAg were co-
transfected with plasmid expressing TAP-tagged histone H1e into COS7 cells.
Cells were lysed 2 days after transfection. Protein bound to TAP-tagged histone
H1e was purified with TAPmethod. The initial lysates and final eluates (denoted
as TAP) were subjected to immunoblot analysis using a human anti-HDAg
antibody. (C) COS7 cells were transfected with plasmids expressing various
isoprenylation mutants or deletion mutants of LHDAg. The cells were harvested
2 days later and subjected to immunoblot analysis using a human anti-HDAg
antibody or an N-terminus specific anti-HDAg antibody.
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deletion mutants of histone H1e. They were pCMVTAP-H2-
34d (deletion of amino acids 2–34), pCMVTAP-H35-99d
(deletion of amino acids 35–99), pCMVTAP-H99d (deletion of
amino acids 99–219), pCMVTAP-H115d (deletion of amino
acids 116–219), pCMVTAP-H135d (deletion of amino acids
136–219), and pCMVTAP-H170d (deletion of amino acids
171–219) respectively (Fig. 4A). When co-transfecting these
plasmids with SHDAg-expressing vector into COS7 cells,
SHDAg could be co-purified with all the TAP-tagged histone
H1e deletion mutants except H35-99d and H99d (Fig. 4B).
Because the central globular region contains amino acid
residues around 35 to 115, it is likely that histone H1e binds
SHDAg through its globular domain.HDV replication is inhibited by deletion mutants of histone H1e
and restored by wild-type histone H1e
To test whether histone H1e will affect HDV replication, we
co-transfected D3, a replication-competent trimer of HDV (Kuo
et al., 1989), with increasing amount of plasmid pcDNA3-H1e,
expressing histone H1e, into COS7 cells. Total RNA was
extracted 4 day post transfection and subjected to northern blot
analysis. The result showed that the level of HDV replication
was not affected by the amount of pcDNA3-H1e transfected
(Fig. 5A and data not shown). One explanation for the result
was that the amount of histone H1e pre-existing in the cells is
sufficient to assist in HDV replication. If this is the case,
deletion mutants of histone H1e with binding affinity to SHDAg
may compete with the wild-type histone H1e for SHDAg
binding and inhibit HDV replication. Furthermore, adding wild-
type histone H1e should reverse this inhibition. We therefore
co-transfected D3 with plasmids expressing N- or C-terminus
deletion mutants of histone H1e into COS7 cells. Northern blot
analysis showed that HDV replication was inhibited by various
deletion mutants of histone H1e, especially N-terminus deletion
mutant, H2-34d (Fig. 5A). This inhibition was not seen when
co-transfecting D3 with plasmid expressing globular domain
deletion mutants of histone H1e, H35-99d, which did not bind
to SHDAg (Fig. 5A). To rule out that the inhibition of HDV
replication was caused by the toxicity of the mutated forms of
H1e in transfected cells, we co-transfected plasmid expressing
Fig. 5. Influence of histone H1e on HDV replication. (A) COS7 cells were co-
transfected with replication-competent HDV trimer D3 and various amounts of
plasmid (pcDNA3.1 based) expressing wild-type or deletion mutants of histone
H1e. The structure of deletion mutants was shown in Fig. 4A. To test the toxicity
of deletion mutant of histone H1e, COS7 cells were transfected with pcDNA3-
LacZ alone or with equal amount of pcDNA3-LacZ and pcDNA3-H2-34d. The
amount of transfected DNA was made equal by adding plasmid pcDNA3.1.
Total cellular RNA was extracted 4 days after transfection and subjected to
northern blot analysis with the antigenomic HDV RNA probe or LacZ DNA
probe (upper) or with glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
probe for RNA loading control (bottom). (B) COS7 cells were co-transfected
with D3 and plasmid expressing N-terminal deletion mutant of histone H1e, and
1 day later were transfected with various amounts of plasmid expressing wild-
type histone H1e. The amount of transfected DNA was made equal by adding
plasmid pCDNA3.1. Total cellular RNAwas extracted 4 days after transfection
and subjected to northern blot analysis as above.
201C.-Z. Lee, J.-C. Sheu / Virology 375 (2008) 197–204LacZ protein and plasmid expressing histone H1e mutant, H2-
34d, into COS7 cells. The LacZ expressing was not inhibited by
H2-34d (Fig. 5A). Thus, the inhibition of HDV replication by
mutant H1e is unlikely caused by toxicity of mutant H1e. We
further co-transfected D3 with plasmids expressing N-terminus
deletion mutant of histone H1e into COS7 cells. One day later,
various amounts of pcDNA3-H1e were transfected into the same
cells. Northern blot analysis showed that the level of HDV
replication increased with the amount of pcDNA3-H1e trans-
fected (Fig. 5B). We concluded that histone H1e can assist in
HDV replication.
Discussion
Histone H1e is one of the variants of linker histone H1,
which is involved in the formation of higher orders of chromatin
structure. It is currently accepted that histone H1 could have a
regulatory role in transcription through the modulation of
chromatin structure. Several studies also show that linker
histones participate in complexes that can either activate or
repress specific genes (Shen and Gorovsky, 1996; Wolffe et al.,
1997; Zlatanova and van Holde, 1992). Histone H1 is
exchanged rapidly and continuously in both condensed and
decondensed chromatin (Lever et al., 2000; Misteli et al., 2000).
Thus, it is readily available for binding to other nuclear proteins.It is interesting to note that nucleolar protein nucleolin (Erard
et al., 1999) induces chromatin decondensation by binding to
H1. Nucleolin has also been shown to bind to HDAg and en-
hance HDV replication (Lee et al., 1998). Is it possible that
histone H1e interacts with SHDAg through binding to
nucleolin? HDAg contains two nucleolin binding sites, spanning
amino acid residues 35–50 and 51–65 respectively (Lee et al.,
1998). In this study, the SHDAg deletion mutant SHDAg2–21,
which retains both nucleolin binding sites, was not able to bind
to histone H1e. Analysis of protein complex from TAP study did
not reveal nucleolin. Furthermore, nucleolin has equal affinity to
both SHDAg and LHDAg (Lee et al., 1998). Thus, it is apparent
that SHDAg interacts with histone H1e and nucleolin through
different mechanisms.
We have demonstrated that N-terminal amino acids 2 to 21 of
SHDAg are essential for interacting with histone H1e. In our
previous study, we found that deletion mutant S2–21 still can
transactivate replication of a replication-deficient HDV dimer
(Lee et al., 1995). The study was based on HDV cDNA con-
struct, which contains several bidirectional promoters potential
for initiation of transcription, and might not mimic authentic
HDV replication (Modahl and Lai, 1998). It is also probable that
without binding to histone H1e, S2–21 can still bind to other
cellular factors (e.g., nucleolin and B23) and modulates HDV
replication. Further RNA transfection approach will resolve this
issue.
Our initial study showed that N-terminal TAP-tagged
SHDAg failed to bind to histone H1e. The plausible explanation
is that TAP tag masks the N-terminus of SHDAg. Unfortunately,
IgG-binding unit of protein A in TAP tag makes probing this
possibility with N-terminus specific anti-HDAg antibody
impossible. When co-expressing N-terminal TAP-tagged
SHDAg and wild-type SHDAg, only histone H1e was purified,
besides probable background ribosomal proteins. We reasoned
that SHDAg binds to histone H1e in oligomer form and that
TAP-tagged SHDAg in the oligomer interferes with further
complex formation. We have tried to fish out other interacting
proteins by co-expressing N-terminal TAP-tagged histone H1e
and SHDAg and purifying with TAP method, but to no avail
(data not shown). Judging from inhibition of HDV replication
by N-terminus deletion mutant of histone H1e, this N-terminus
is likely involved in protein–protein interaction. We suspected
that this domain is also masked in N-terminal TAP-tagged
histone H1e. Our results suggested that TAP tag might interfere
with complex assembly if the tagged protein has functional
domain in its N-terminus. The C-terminal TAP tag has also been
shown to interfere with protein complex formation (Gavin et al.,
2002). In the study of yeast proteomics, of the 589 purified
tagged proteins, 22% were unable to identify interacting
proteins (Gavin et al., 2002). Since C-terminus is indispensable
for the biological function of SHDAg, C-terminal TAP tag
likely will also interfere with its interaction with other proteins.
H170d, which had 49 amino acids deleted from C-terminus of
Histone H1e, seemed to have less effect on inhibition of HDV
replication (Fig. 5A). Probably, C-terminal TAP-tagged histone
H1e can be a candidate target protein for further characterization
of proteins that form complex with histone H1e and SHDAg.
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additional 19 amino acids at the carboxyl terminus. Why is only
SHDAg, not LHDAg, required for HDV replication? One
explanation is that isoprenylation of LHDAg at the C-terminus
masks a conformational epitope at the C-terminus of SHDAg
(Hwang and Lai, 1994). This C-terminus had been shown to bind
to Pol II and promote transcription elongation (Yamaguchi et al.,
2001). However, in that study, LHDAg also bound to Pol II and
promoted transcription elongation, although less effective than
SHDAg did. So far, no other cellular protein has been shown to
bind to the C-terminus of SHDAg. Histone H1e, to our knowl-
edge, is the first found cellular factor that binds differentially to
two isoforms of HDAg and modulates HDV replication. It is
likely to play a significant role in HDV replication.
Materials and methods
Construction of plasmids
All the HDV constructs were made from the cDNA clones of
the Southern California isolate of HDV RNA (Markino et al.,
1987). All the mutations were made by the recombinant PCR
method described by Higuchi et al. (1988). The pCMV-TAP
vector, which contains a cassette coding for IgG-binding unit of
protein A, a TEV protease cleavage site and calmodulin binding
peptide (CBP), was obtained from European Molecular Biology
Laboratory. Plasmid pCMV-TAP-S was made by inserting
coding region of SHDAg into the EcoRI site of the pCMV-
TAP vector, and expressed TAP-tagged SHDAg. Plasmids
pcDNA3-L and pcDNA3-S were made by inserting BglII–
EcoRI fragment of HDV cDNA into BamHI and EcoRI sites of
the pcDNA3 vector (Invitrogen), and expressed the wild-type
LHDAg and SHDAg respectively. The deletion mutants of
SHDAg were derived from pcDNA3-S. Plasmids pCMV-TAP-
H1e and pCMV-TAP-H-ras were made by inserting the histone
H1e-coding region, amplified from a COS7 cell cDNA, or H-ras-
coding region, into the EcoRI site of the pCMV-TAP vector,
respectively. Plasmid pcDNA3-H1e was made by inserting the
histone H1e-coding region into the pcDNA3.1 vector (Invitro-
gen). The deletion mutants of histone H1e were derived from
pCMV-TAP-H1e and pcDNA3-H1e. Primers for amplifying
histone H1e cDNAwere 5'-ATTGCTCTCGCTCACGCTTGC-
3′, 5′-CCGAGCCACGCCCCCTAAT-3′, 5′-CCGAATTCCA-
TGTCCGAGACTGCGCCTGC-3' and 5'-CCGAATTCC-
TACTTTTTCTTGGCTGCCG-3′. The last two primers were
for cloning into pCMV-TAP EcoRI site. Plasmids PECE-I1, I2,
I3, N5,M5 andC5,which express various LHDAgmutants, were
from previous study (Lee et al., 1994). Plasmid pcDNA3-LacZ,
which expresses LacZ, was from Invitrogen.
Tandem affinity purification
Purification method was performed according to standard
method (Puig et al., 2001; Rigaut et al., 1999). The transfected
cells from one 10-cm Petri dish were washed twice with buffer A
(10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM
dithiothreitol, 0.5 mM EDTA, and 1% Complete™ proteaseinhibitor cocktail (Boehringer Mannheim)), then lysed on ice for
5 min with 1 ml of buffer B (20 mM HEPES, pH 7.9, 20%
glycerol, 200 mM KCl, 0.5 mM DTT, 0.5 mM EDTA, 1%
protease inhibitor, and 0.5% Nonidet P-40). The lysed cells were
aspirated off the dish, sheared by high-speed vibration, and
cleared by centrifuged at 10000 g for 10 min. The supernatant
was incubated with 100 μl of IgG sepharose (Amersham) for 2 h
at 4 °C using a rotating wheel. The sepharose was spinned down
at 300 g for 1min, andwaswashed three times with buffer B, four
times with buffer C (20 mM HEPES, pH 7.9, 20% glycerol,
200 mM KCl, 0.5 mM dithiothreitol, 0.5 mM EDTA, and 0.1%
Nonidet P-40), and three timeswith TEV cleavage buffer (10mM
Tris–Cl, pH 8, 150 mM NaCl, 0.1% Nonidet P-40, 0.5 mM
dithiothreitol, and 0.5 mMEDTA). The sepharose was incubated
with 20 U of TEV protease (Invitrogen) in 200 μl of TEV
cleavage buffer at 4 °C overnight using a rotating wheel and was
then centrifuged at 300 g for 1min. The supernatant was taken off
and 0.6 μl 1MCaCl2 was added. This supernatant was combined
with 600 μl of calmodulin binding buffer (10 mM Tris–Cl, pH 8,
10 mM beta-mercaptoethanol, 150mMNaCl, 1 mMMg-acetate,
1 mM Imidazole, 2 mM CaCl2, and 0.1% Nonidet P-40) and
incubated with 50 μl of calmodulin resin (Stratagene) for 2 h at
4 °C. The resin was washed five times with calmodulin binding
buffer and eluted with 50 μl of Laemmli sample buffer.
For detection of cellular factors interacting with SHDAg,
transfected cells were collected from fifteen 10-cm Petri dishes
for TAP and protein identification. For detection of interaction
between histone H1e and HDAg or their mutants, transfected
cells from one 10-cm Petri dish were collected. Twenty
microliter of the initial lysate was saved for immunoblot. The
remaining lysate went through TAP procedure and half of the
final eluate was used for immunoblot.
Protein identification
The eluted sample from TAP was separated by SDS-
polyacrylamide gel electrophoresis (10% polyacrylamide) and
stained by Coomassie blue. The distinct band was excised from
gel and subjected to mass spectrometry analysis by 4700
Proteomics Analyzer (Applied Biosystems).
Cell lines, DNA transfections and sample harvest
The African green monkey kidney cell line COS7 and human
hepatoma cell line Huh7 were used as the recipient cells for DNA
transfection. The cell line was maintained in Dulbecco's modi-
fied Eagle essential medium containing 10% fetal calf serum. All
DNA transfection experiments were performed by the use of the
Effectene reagent (Qiagene) according to the manufacturer's
directions. Cells were transfected at 60% confluency and
harvested 2 to 4 days posttransfection. For immunoblot analysis,
the cells went through TAP procedure or were directly scraped
off the Petri dish and resuspended in Laemmli sample buffer.
For northern blot assay, the total cellular RNA was extracted
by the modified acid guanidinium isothiocyanate method
(Chomczynski, 1993) using the TRIzol reagent (BRL/Life
Technology).
203C.-Z. Lee, J.-C. Sheu / Virology 375 (2008) 197–204Immunoblot analysis
Protein samples were separated by SDS-polyacrylamide gel
electrophoresis (10% polyacrylamide) and electrotransferred to
nitrocellulose membranes. The membranes were first incubated
with 5% nonfat milk and then with a human anti-HDAg
antibody or an N-terminus specific monoclonal mouse anti-
HDAg antibody, a byproduct from the study of Hwang and Lai
(1993). The horseradish peroxidase-conjugated rabbit anti-
human (Promega) or goat anti-mouse (Promega) immunoglo-
bulin antibody was used as the second antibody. ECL (Pierce)
was used as a substrate for chemiluminescence development
according to the manufacturer's instructions.
Northern (RNA) blot analysis
RNA samples (20 μg) were electrophoresed in a formalde-
hyde gel and transferred to a nitrocellulose membrane. The
membrane was baked at 80 °C for 2 h, prehybridized for 6 h, and
hybridized at 65 °C overnight with digoxigenin-labeled
antigenomic HDV RNA. The membrane was washed twice at
room temperature and twice at 68 °C and then detected with
alkaline phosphatase-conjugated goat anti-digoxigenin antibody
(Boehringer, Mannheim). Lumi-phos (Boehringer Mannheim)
was used as a substrate for chemiluminescence development
according to the manufacturer's instructions.
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